Global Markets and Manufacturing Technologies for Protein Drugs
Report Scope:
This report will focus on protein drugs, classification and manufacturing technologies. The protein drugs market can be classified into peptide hormones, monoclonal antibodies, cytokines, therapeutic enzymes, blood factors, vaccines and peptide antibiotics. This report focuses on six techniques for manufacturing protein therapeutics, including fractionation from natural human/animal sources, microbial fermentation, cell culture, chemical synthesis, transgenics and embryonated eggs. The report focuses on each market and its applications, regulatory environment, latest trends and developments, drivers, restraints and challenges affecting the market.
The report covers company profiles for all the major companies and also company share analysis. This report also covers market projections to 2026 and relevant patent analysis. By geography, the market has been segmented into the United States, Europe and emerging markets. Emerging markets include India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand. For market estimates, data has been provided for the year 2019, 2020 (as base year) and forecast through 2026.
Report Includes:
This report will focus on protein drugs, classification and manufacturing technologies. The protein drugs market can be classified into peptide hormones, monoclonal antibodies, cytokines, therapeutic enzymes, blood factors, vaccines and peptide antibiotics. This report focuses on six techniques for manufacturing protein therapeutics, including fractionation from natural human/animal sources, microbial fermentation, cell culture, chemical synthesis, transgenics and embryonated eggs. The report focuses on each market and its applications, regulatory environment, latest trends and developments, drivers, restraints and challenges affecting the market.
The report covers company profiles for all the major companies and also company share analysis. This report also covers market projections to 2026 and relevant patent analysis. By geography, the market has been segmented into the United States, Europe and emerging markets. Emerging markets include India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand. For market estimates, data has been provided for the year 2019, 2020 (as base year) and forecast through 2026.
Report Includes:
- 37 data tables and 28 additional tables
- An overview of the global markets and manufacturing technologies for protein drugs
- Estimation of the market size and analyses of global market trends, with data from 2019 to 2020, estimates for 2021 with projections of compound annual growth rates (CAGRs) through 2026
- Highlights of the current and future market potential and quantification of protein drugs market based on type, manufacturing process and region
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
- Detailed description of protein drugs, their classification and six main manufacturing technologies and information on recombinant deoxyribonucleic acid (rDNA) technology
- Information on advancements in manufacturing technologies, new product launches of the industry and discussion on effect of biosimilars entry to the protein drugs market
- Detailed analysis of the regulatory framework and policies and technological changes within the industry
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
- Comprehensive company profiles of the leading players of the industry, including AbbVie Inc., Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Pfizer Inc. and Sanofi S.A.
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Update?
Scope of Report
Information Sources
Research Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 THERAPEUTIC PROTEINS: OVERVIEW
History
Pharmacological Classification of Therapeutic Proteins
Protein Therapeutics with Enzymatic or Regulatory Activity
Protein Therapeutics with Special Targeting Activity
Protein Vaccines
Molecular Classification of Therapeutic Proteins
Cytokines
Monoclonal Antibodies
Blood Products
Peptide Antibiotics
Vaccines
Enzymes
Peptide Hormones
Manufacturing Technologies
Fractionation/Extraction from Natural Sources (Human/Animal)
Microbial Fermentation and Bioreactors
Transgenics
Mammalian Cell Culture
CHAPTER 4 REGULATORY ASPECTS
Monoclonal Antibodies
Therapeutic Enzymes
Cytokines
Peptide Hormones
Vaccines
Blood Products
Peptide Antibiotics
Recalls and Safety Alerts
CHAPTER 5 NEW DEVELOPMENTS
Monoclonal Antibodies
Vaccines
Cytokines
Peptide Hormones
Therapeutic Enzymes
Blood Products
Peptide Antibiotics
CHAPTER 6 MARKET ANALYSIS OF PROTEIN DRUGS BY TYPE
Global Market for Protein Drugs by Type
Market Share
Monoclonal Antibodies
Peptide Hormones
Vaccines
Blood Factors
Cytokines
Therapeutic Enzymes
Peptide Antibiotics
CHAPTER 7 MARKET ANALYSIS OF PROTEIN DRUGS BY REGION
Global Market for Protein Drugs by Region
Market Share
Regional Markets for Monoclonal Antibodies
Regional Markets for Peptide Hormones
Regional Markets for Vaccines
Regional Markets for Blood Factors
Regional Markets for Cytokines
Regional Markets for Therapeutic Enzymes
Regional Markets for Peptide Antibiotics
CHAPTER 8 MARKET ANALYSIS OF PROTEIN DRUGS BY MANUFACTURING PROCESS
Global Market for Protein Drugs by Manufacturing Process
Market Share
Monoclonal Antibodies
Peptide Hormones
Vaccines
Blood Factors
Cytokines
Therapeutic Enzymes
Peptide Antibiotics
CHAPTER 9 COMPETITIVE LANDSCAPE
Mergers and Acquisitions
Monoclonal Antibodies
Market Share
Peptide Hormones
Market Share
Vaccines
Market Share
Blood Factors
Market Share
Cytokines
Market Share
Therapeutic Enzymes
Market Share
Peptide Antibiotics
Market Share
CHAPTER 10 MARKET DYNAMICS
Market Drivers
Prevalence of Chronic Diseases
Growing Aging Population
Advancements in Manufacturing Technologies
New Product Launches
Licensing and Collaboration Agreements
Market Challenges
Price Controls
Regulatory Pressures
Entry of Biosimilars
Impact of COVID-19 on Protein Drugs Market
CHAPTER 11 PATENT ANALYSIS
CHAPTER 12 COMPANY PROFILES
ABBVIE INC.
ALEXION PHARMACEUTICALS
AMGEN INC.
APOTEX INC.
BAYER PHARMACEUTICALS
BIOGEN
BIOMARIN PHARMACEUTICAL INC.
BRISTOL-MYERS SQUIBB
BIOTEST
CSL LTD.
ELI LILLY
F. HOFFMANN-LA ROCHE AG
FRESENIUS KABI
GLAXOSMITHKLINE
GRIFOLS S.A.
JOHNSON & JOHNSON
MERCK & CO., INC.
MERCK KGAA
NOVO NORDISK AG
NOVARTIS AG
OCTAPHARMA AG
PFIZER INC.
SANDOZ
SANOFI S.A.
SEAGEN
TAKEDA PHARMACEUTICAL CO., LTD.
UCB CO.
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Update?
Scope of Report
Information Sources
Research Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 THERAPEUTIC PROTEINS: OVERVIEW
History
Pharmacological Classification of Therapeutic Proteins
Protein Therapeutics with Enzymatic or Regulatory Activity
Protein Therapeutics with Special Targeting Activity
Protein Vaccines
Molecular Classification of Therapeutic Proteins
Cytokines
Monoclonal Antibodies
Blood Products
Peptide Antibiotics
Vaccines
Enzymes
Peptide Hormones
Manufacturing Technologies
Fractionation/Extraction from Natural Sources (Human/Animal)
Microbial Fermentation and Bioreactors
Transgenics
Mammalian Cell Culture
CHAPTER 4 REGULATORY ASPECTS
Monoclonal Antibodies
Therapeutic Enzymes
Cytokines
Peptide Hormones
Vaccines
Blood Products
Peptide Antibiotics
Recalls and Safety Alerts
CHAPTER 5 NEW DEVELOPMENTS
Monoclonal Antibodies
Vaccines
Cytokines
Peptide Hormones
Therapeutic Enzymes
Blood Products
Peptide Antibiotics
CHAPTER 6 MARKET ANALYSIS OF PROTEIN DRUGS BY TYPE
Global Market for Protein Drugs by Type
Market Share
Monoclonal Antibodies
Peptide Hormones
Vaccines
Blood Factors
Cytokines
Therapeutic Enzymes
Peptide Antibiotics
CHAPTER 7 MARKET ANALYSIS OF PROTEIN DRUGS BY REGION
Global Market for Protein Drugs by Region
Market Share
Regional Markets for Monoclonal Antibodies
Regional Markets for Peptide Hormones
Regional Markets for Vaccines
Regional Markets for Blood Factors
Regional Markets for Cytokines
Regional Markets for Therapeutic Enzymes
Regional Markets for Peptide Antibiotics
CHAPTER 8 MARKET ANALYSIS OF PROTEIN DRUGS BY MANUFACTURING PROCESS
Global Market for Protein Drugs by Manufacturing Process
Market Share
Monoclonal Antibodies
Peptide Hormones
Vaccines
Blood Factors
Cytokines
Therapeutic Enzymes
Peptide Antibiotics
CHAPTER 9 COMPETITIVE LANDSCAPE
Mergers and Acquisitions
Monoclonal Antibodies
Market Share
Peptide Hormones
Market Share
Vaccines
Market Share
Blood Factors
Market Share
Cytokines
Market Share
Therapeutic Enzymes
Market Share
Peptide Antibiotics
Market Share
CHAPTER 10 MARKET DYNAMICS
Market Drivers
Prevalence of Chronic Diseases
Growing Aging Population
Advancements in Manufacturing Technologies
New Product Launches
Licensing and Collaboration Agreements
Market Challenges
Price Controls
Regulatory Pressures
Entry of Biosimilars
Impact of COVID-19 on Protein Drugs Market
CHAPTER 11 PATENT ANALYSIS
CHAPTER 12 COMPANY PROFILES
ABBVIE INC.
ALEXION PHARMACEUTICALS
AMGEN INC.
APOTEX INC.
BAYER PHARMACEUTICALS
BIOGEN
BIOMARIN PHARMACEUTICAL INC.
BRISTOL-MYERS SQUIBB
BIOTEST
CSL LTD.
ELI LILLY
F. HOFFMANN-LA ROCHE AG
FRESENIUS KABI
GLAXOSMITHKLINE
GRIFOLS S.A.
JOHNSON & JOHNSON
MERCK & CO., INC.
MERCK KGAA
NOVO NORDISK AG
NOVARTIS AG
OCTAPHARMA AG
PFIZER INC.
SANDOZ
SANOFI S.A.
SEAGEN
TAKEDA PHARMACEUTICAL CO., LTD.
UCB CO.
LIST OF TABLES
Summary Table: Global Market for Protein Drugs, by Type, Through 2026
Table 1: Evolution of Therapeutic Proteins
Table 2: Protein Drugs Made by Fractionation
Table 3: Therapeutic Drugs Produced by Microbial Fermentation
Table 4: Protein Drugs Produced by Transgenic Animals, Plants and Microorganisms
Table 5: Protein Drugs Made by Cell Culture
Table 6: Newly Approved Monoclonal Antibodies, 2019-May 2021
Table 7: Newly Approved Peptide Hormones, 2019-May 2021
Table 8: Newly Approved Vaccines, 2019-May 2021
Table 9: Newly Approved Blood Products, 2019-May 2021
Table 10: Newly Approved Peptide Antibiotics, 2019-May 2021
Table 11: Recalls and Safety Alerts, 2019-May 2021
Table 12: Pipeline Products: Monoclonal Antibodies
Table 13: Pipeline Products: Vaccines
Table 14: Pipeline Products: Cytokines
Table 15: Pipeline Products: Peptide Hormones
Table 16: Pipeline Products: Therapeutic Enzymes
Table 17: Pipeline Products: Peptide Hormones
Table 18: Pipeline Products: Peptide Antibiotics
Table 19: Global Market for Protein Drugs, Through 2026
Table 20: Global Market for Protein Drugs, by Type, Through 2026
Table 21: Global Market for Monoclonal Antibodies, by Type, Through 2026
Table 22: Global Market for Peptide Hormones, by Type, Through 2026
Table 23: Global Market for Vaccines, by Type, Through 2026
Table 24: Global Market for Blood Factors, by Type, Through 2026
Table 25: Global Market for Cytokines, by Type, Through 2026
Table 26: Global Market for Therapeutic Enzymes, by Type, Through 2026
Table 27: Global Market for Peptide Antibiotics, by Type, Through 2026
Table 28: Global Market for Protein Drugs, by Region, Through 2026
Table 29: Global Market for Monoclonal Antibodies, by Region, Through 2026
Table 30: Global Market for Peptide Hormones, by Region, Through 2026
Table 31: Global Market for Vaccines, by Region, Through 2026
Table 32: Global Market for Blood Factors, by Region, Through 2026
Table 33: Global Market for Cytokines, by Region, Through 2026
Table 34: Global Market for Therapeutic Enzymes, by Region, Through 2026
Table 35: Global Market for Peptide Antibiotics, by Region, Through 2026
Table 36: Global Market for Protein Drugs, by Manufacturing Process, Through 2026
Table 37: Global Market for Monoclonal Antibodies, by Manufacturing Process, Through 2026
Table 38: Global Market for Peptide Hormones, by Manufacturing Process, Through 2026
Table 39: Global Market for Vaccines, by Manufacturing Process, Through 2026
Table 40: Global Market for Blood Factors, by Manufacturing Process, Through 2026
Table 41: Global Market for Cytokines, by Manufacturing Process, Through 2026
Table 42: Global Market for Therapeutic Enzymes, by Manufacturing Process, Through 2026
Table 43: Global Market for Peptide Antibiotics, by Manufacturing Process, Through 2026
Table 44: Mergers and Acquisitions: Pharmaceutical Companies
Table 45: AbbVie Inc.: Business Segments
Table 46: AbbVie Inc.: Financial Performance, 2018-2020
Table 47: Amgen: Financial Performance, 2018-2020
Table 48: Bristol-Myers Squibb: Financial Performance, 2018-2020
Table 49: Eli Lilly: Business Segments
Table 50: Eli Lilly: Financial Performance, 2018-2020
Table 51: F. Hoffmann-La Roche: Business Segments
Table 52: F. Hoffmann-La Roche: Financial Performance, 2018-2020
Table 53: GlaxoSmithKline: Product Segments
Table 54: GlaxoSmithKline: Financial Performance, 2018-2020
Table 55: Johnson & Johnson: Business Segments
Table 56: Johnson & Johnson: Financial Performance, 2018-2020
Table 57: Merck & Co., Inc.: Business Segments
Table 58: Merck & Co., Inc.: Financial Performance, 2018-2020
Table 59: Novo Nordisk: Business Segments
Table 60: Novo Nordisk: Financial Performance, 2018-2020
Table 61: Pfizer: Business Segments
Table 62: Pfizer: Financial Performance, 2018-2020
Table 63: Sanofi: Business Segments
Table 64: Sanofi: Financial Performance, 2018-2020
Summary Table: Global Market for Protein Drugs, by Type, Through 2026
Table 1: Evolution of Therapeutic Proteins
Table 2: Protein Drugs Made by Fractionation
Table 3: Therapeutic Drugs Produced by Microbial Fermentation
Table 4: Protein Drugs Produced by Transgenic Animals, Plants and Microorganisms
Table 5: Protein Drugs Made by Cell Culture
Table 6: Newly Approved Monoclonal Antibodies, 2019-May 2021
Table 7: Newly Approved Peptide Hormones, 2019-May 2021
Table 8: Newly Approved Vaccines, 2019-May 2021
Table 9: Newly Approved Blood Products, 2019-May 2021
Table 10: Newly Approved Peptide Antibiotics, 2019-May 2021
Table 11: Recalls and Safety Alerts, 2019-May 2021
Table 12: Pipeline Products: Monoclonal Antibodies
Table 13: Pipeline Products: Vaccines
Table 14: Pipeline Products: Cytokines
Table 15: Pipeline Products: Peptide Hormones
Table 16: Pipeline Products: Therapeutic Enzymes
Table 17: Pipeline Products: Peptide Hormones
Table 18: Pipeline Products: Peptide Antibiotics
Table 19: Global Market for Protein Drugs, Through 2026
Table 20: Global Market for Protein Drugs, by Type, Through 2026
Table 21: Global Market for Monoclonal Antibodies, by Type, Through 2026
Table 22: Global Market for Peptide Hormones, by Type, Through 2026
Table 23: Global Market for Vaccines, by Type, Through 2026
Table 24: Global Market for Blood Factors, by Type, Through 2026
Table 25: Global Market for Cytokines, by Type, Through 2026
Table 26: Global Market for Therapeutic Enzymes, by Type, Through 2026
Table 27: Global Market for Peptide Antibiotics, by Type, Through 2026
Table 28: Global Market for Protein Drugs, by Region, Through 2026
Table 29: Global Market for Monoclonal Antibodies, by Region, Through 2026
Table 30: Global Market for Peptide Hormones, by Region, Through 2026
Table 31: Global Market for Vaccines, by Region, Through 2026
Table 32: Global Market for Blood Factors, by Region, Through 2026
Table 33: Global Market for Cytokines, by Region, Through 2026
Table 34: Global Market for Therapeutic Enzymes, by Region, Through 2026
Table 35: Global Market for Peptide Antibiotics, by Region, Through 2026
Table 36: Global Market for Protein Drugs, by Manufacturing Process, Through 2026
Table 37: Global Market for Monoclonal Antibodies, by Manufacturing Process, Through 2026
Table 38: Global Market for Peptide Hormones, by Manufacturing Process, Through 2026
Table 39: Global Market for Vaccines, by Manufacturing Process, Through 2026
Table 40: Global Market for Blood Factors, by Manufacturing Process, Through 2026
Table 41: Global Market for Cytokines, by Manufacturing Process, Through 2026
Table 42: Global Market for Therapeutic Enzymes, by Manufacturing Process, Through 2026
Table 43: Global Market for Peptide Antibiotics, by Manufacturing Process, Through 2026
Table 44: Mergers and Acquisitions: Pharmaceutical Companies
Table 45: AbbVie Inc.: Business Segments
Table 46: AbbVie Inc.: Financial Performance, 2018-2020
Table 47: Amgen: Financial Performance, 2018-2020
Table 48: Bristol-Myers Squibb: Financial Performance, 2018-2020
Table 49: Eli Lilly: Business Segments
Table 50: Eli Lilly: Financial Performance, 2018-2020
Table 51: F. Hoffmann-La Roche: Business Segments
Table 52: F. Hoffmann-La Roche: Financial Performance, 2018-2020
Table 53: GlaxoSmithKline: Product Segments
Table 54: GlaxoSmithKline: Financial Performance, 2018-2020
Table 55: Johnson & Johnson: Business Segments
Table 56: Johnson & Johnson: Financial Performance, 2018-2020
Table 57: Merck & Co., Inc.: Business Segments
Table 58: Merck & Co., Inc.: Financial Performance, 2018-2020
Table 59: Novo Nordisk: Business Segments
Table 60: Novo Nordisk: Financial Performance, 2018-2020
Table 61: Pfizer: Business Segments
Table 62: Pfizer: Financial Performance, 2018-2020
Table 63: Sanofi: Business Segments
Table 64: Sanofi: Financial Performance, 2018-2020
LIST OF FIGURES
Summary Figure: Global Market for Protein Drugs, by Type, 2019-2026
Figure 1: Global Market for Protein Drugs, 2019-2026
Figure 2: Global Market Shares of Protein Drugs, by Type, 2020
Figure 3: Global Market for Monoclonal Antibodies, by Type, 2019-2026
Figure 4: Global Market for Peptide Hormones, by Type, 2019-2026
Figure 5: Global Market for Vaccines, by Type, 2019-2026
Figure 6: Global Market for Blood Factors, by Type, 2019-2026
Figure 7: Global Market for Cytokines, by Type, 2019-2026
Figure 8: Global Market for Therapeutic Enzymes, by Type, 2019-2026
Figure 9: Global Market for Peptide Antibiotics, by Type, 2019-2026
Figure 10: Global Market for Protein Drugs, by Region, 2019-2026
Figure 11: Global Market Shares of Protein Drugs, by Region, 2020
Figure 12: Global Market for Monoclonal Antibodies, by Region, 2019-2026
Figure 13: Global Market for Peptide Hormones, by Region, 2019-2026
Figure 14: Global Market for Vaccines, by Region, 2019-2026
Figure 15: Global Market for Blood Factors, by Region, 2019-2026
Figure 16: Global Market for Cytokines, by Region, 2019-2026
Figure 17: Global Market for Therapeutic Enzymes, by Region, 2019-2026
Figure 18: Global Market for Peptide Antibiotics, by Region, 2019-2026
Figure 19: Global Market for Protein Drugs, by Manufacturing Process, 2019-2026
Figure 20: Global Market Shares of Protein Drugs, by Manufacturing Process, 2020
Figure 21: Global Market for Monoclonal Antibodies, by Manufacturing Process, 2019-2026
Figure 22: Global Market for Peptide Hormones, by Manufacturing Process, 2019-2026
Figure 23: Global Market for Vaccines, by Manufacturing Process, 2019-2026
Figure 24: Global Market for Blood Factors, by Manufacturing Process, 2019-2026
Figure 25: Global Market for Cytokines, by Manufacturing Process, 2019-2026
Figure 26: Global Market for Therapeutic Enzymes, by Manufacturing Process, 2019-2026
Figure 27: Global Market for Peptide Antibiotics, by Manufacturing Process, 2019-2026
Figure 28: Global Manufacturer/Supplier Market Shares of Monoclonal Antibodies, 2020
Figure 29: Global Manufacturer/Supplier Market Shares of Peptide Hormones, 2020
Figure 30: Global Manufacturer/Supplier Market Shares of Vaccines, 2020
Figure 31: Global Manufacturer/Supplier Market Shares of Blood Factors, 2020
Figure 32: Global Manufacturer/Suppliers Market Shares of Cytokines, 2020
Figure 33: Global Manufacturer/Supplier Market Shares of Therapeutic Enzymes, 2020
Figure 34: Global Manufacturer/Supplier Market Shares of Peptide Antibiotics, 2020
Figure 35: AbbVie Inc.: Net Revenue Share, by Business Segment, 2020
Figure 36: AbbVie Inc.: Net Revenue Share, by Region, 2020
Figure 37: Amgen: Total Sales Share, by Product Segment, 2020
Figure 38: Amgen: Total Revenue Share, by Region, 2020
Figure 39: Bristol Myers Squibb: Total Sales Share, by Product Segment, 2020
Figure 40: Company website/financial filings
Figure 41: Eli Lilly: Total Sales Share, by Product Segment, 2020
Figure 42: Eli Lilly: Total Revenue Share, by Region, 2020
Figure 43: F. Hoffmann-La Roche: Total Sales Share, by Product Segment, 2020
Figure 44: F. Hoffmann-La Roche: Total Revenue Share, by Region, 2020
Figure 45: GlaxoSmithKline: Total Sales Share, by Product Segment, 2020
Figure 46: GlaxoSmithKline: Total Revenue Share, by Region, 2020
Figure 47: Johnson & Johnson: Total Sales Share, by Business Segment, 2020
Figure 48: Johnson & Johnson: Total Revenue Share, by Region, 2020
Figure 49: Merck & Co., Inc.: Revenue Share, by Business Segment, 2020
Figure 50: Merck & Co., Inc.: Revenue Share, by Region, 2020
Figure 51: Novo Nordisk: Revenue Share, by Business Segment, 2020
Figure 52: Novo Nordisk: Revenue Share, by Region, 2020
Figure 53: Pfizer: Revenue Share, by Business Segment, 2020
Figure 54: Pfizer: Revenue Share, by Region, 2020
Figure 55: Sanofi: Net Sales Share, by Business Segment, 2020
Figure 56: Sanofi: Net Sales Share, by Region, 2020
Summary Figure: Global Market for Protein Drugs, by Type, 2019-2026
Figure 1: Global Market for Protein Drugs, 2019-2026
Figure 2: Global Market Shares of Protein Drugs, by Type, 2020
Figure 3: Global Market for Monoclonal Antibodies, by Type, 2019-2026
Figure 4: Global Market for Peptide Hormones, by Type, 2019-2026
Figure 5: Global Market for Vaccines, by Type, 2019-2026
Figure 6: Global Market for Blood Factors, by Type, 2019-2026
Figure 7: Global Market for Cytokines, by Type, 2019-2026
Figure 8: Global Market for Therapeutic Enzymes, by Type, 2019-2026
Figure 9: Global Market for Peptide Antibiotics, by Type, 2019-2026
Figure 10: Global Market for Protein Drugs, by Region, 2019-2026
Figure 11: Global Market Shares of Protein Drugs, by Region, 2020
Figure 12: Global Market for Monoclonal Antibodies, by Region, 2019-2026
Figure 13: Global Market for Peptide Hormones, by Region, 2019-2026
Figure 14: Global Market for Vaccines, by Region, 2019-2026
Figure 15: Global Market for Blood Factors, by Region, 2019-2026
Figure 16: Global Market for Cytokines, by Region, 2019-2026
Figure 17: Global Market for Therapeutic Enzymes, by Region, 2019-2026
Figure 18: Global Market for Peptide Antibiotics, by Region, 2019-2026
Figure 19: Global Market for Protein Drugs, by Manufacturing Process, 2019-2026
Figure 20: Global Market Shares of Protein Drugs, by Manufacturing Process, 2020
Figure 21: Global Market for Monoclonal Antibodies, by Manufacturing Process, 2019-2026
Figure 22: Global Market for Peptide Hormones, by Manufacturing Process, 2019-2026
Figure 23: Global Market for Vaccines, by Manufacturing Process, 2019-2026
Figure 24: Global Market for Blood Factors, by Manufacturing Process, 2019-2026
Figure 25: Global Market for Cytokines, by Manufacturing Process, 2019-2026
Figure 26: Global Market for Therapeutic Enzymes, by Manufacturing Process, 2019-2026
Figure 27: Global Market for Peptide Antibiotics, by Manufacturing Process, 2019-2026
Figure 28: Global Manufacturer/Supplier Market Shares of Monoclonal Antibodies, 2020
Figure 29: Global Manufacturer/Supplier Market Shares of Peptide Hormones, 2020
Figure 30: Global Manufacturer/Supplier Market Shares of Vaccines, 2020
Figure 31: Global Manufacturer/Supplier Market Shares of Blood Factors, 2020
Figure 32: Global Manufacturer/Suppliers Market Shares of Cytokines, 2020
Figure 33: Global Manufacturer/Supplier Market Shares of Therapeutic Enzymes, 2020
Figure 34: Global Manufacturer/Supplier Market Shares of Peptide Antibiotics, 2020
Figure 35: AbbVie Inc.: Net Revenue Share, by Business Segment, 2020
Figure 36: AbbVie Inc.: Net Revenue Share, by Region, 2020
Figure 37: Amgen: Total Sales Share, by Product Segment, 2020
Figure 38: Amgen: Total Revenue Share, by Region, 2020
Figure 39: Bristol Myers Squibb: Total Sales Share, by Product Segment, 2020
Figure 40: Company website/financial filings
Figure 41: Eli Lilly: Total Sales Share, by Product Segment, 2020
Figure 42: Eli Lilly: Total Revenue Share, by Region, 2020
Figure 43: F. Hoffmann-La Roche: Total Sales Share, by Product Segment, 2020
Figure 44: F. Hoffmann-La Roche: Total Revenue Share, by Region, 2020
Figure 45: GlaxoSmithKline: Total Sales Share, by Product Segment, 2020
Figure 46: GlaxoSmithKline: Total Revenue Share, by Region, 2020
Figure 47: Johnson & Johnson: Total Sales Share, by Business Segment, 2020
Figure 48: Johnson & Johnson: Total Revenue Share, by Region, 2020
Figure 49: Merck & Co., Inc.: Revenue Share, by Business Segment, 2020
Figure 50: Merck & Co., Inc.: Revenue Share, by Region, 2020
Figure 51: Novo Nordisk: Revenue Share, by Business Segment, 2020
Figure 52: Novo Nordisk: Revenue Share, by Region, 2020
Figure 53: Pfizer: Revenue Share, by Business Segment, 2020
Figure 54: Pfizer: Revenue Share, by Region, 2020
Figure 55: Sanofi: Net Sales Share, by Business Segment, 2020
Figure 56: Sanofi: Net Sales Share, by Region, 2020
